A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.
Morning Overview on MSN
Metformin may mimic exercise-linked metabolite in prostate cancer patients
Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl ...
A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
Among patients receiving metformin, Lac-Phe levels rose and remained elevated even after hormone therapy began. However, the ...
Discover more about how nutrition and lifestyle interventions can improve the quality of life of patients with prostate ...
A COMMON drug already given to millions of Brits could mimic the effects of “intense” exercise in people who can’t work out, ...
Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results